MCM
BCAB icon

MAI Capital Management’s BioAtla BCAB Stock Holding History

MAI Capital Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.29K Hold
1,030
– – ﹤0.01% 3255
2025
Q4 		$29.2K Buy
1,030
+128
+14% +$5.02K ﹤0.01% 2316
2025
Q3 		$31K Buy
902
+17
+2% +$392 ﹤0.01% 2187
2025
Q2 		$17.5K Buy
885
+690
+354% +$14K ﹤0.01% 2411
2025
Q1 		$3.38K Sell
195
-437
-69% -$9.35K ﹤0.01% 2846
2024
Q4 		$18.7K Sell
632
-8,410
-93% -$706K ﹤0.01% 2251
2024
Q3 		$796K Sell
9,042
-510
-5% -$42.8K 0.01% 622
2024
Q2 		$654K Buy
9,552
+2,944
+45% +$350K 0.01% 718
2024
Q1 		$1.14M Buy
+6,608
New +$821K 0.01% 536

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MAI Capital Management's BCAB Position: Q1 2026 in Review

MAI Capital Management held its BioAtla (BCAB) position steady in Q1 2026 at 1,030 shares worth $8.29K. The position accounts for ﹤0.01% of the portfolio, ranked #3255.

MAI Capital Management first reported a position in BCAB in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.14M in Q1 2024. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • MAI Capital Management held 1,030 shares of BioAtla worth $8.29K as of Q1 2026.
  • MAI Capital Management left its BioAtla share count unchanged in Q1 2026.
  • BioAtla made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #3255 holding.
  • MAI Capital Management first reported a position in BioAtla in Q1 2024 and has held it in 9 quarters since.
  • MAI Capital Management's BioAtla position peaked at $1.14M in Q1 2024.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.